Haemodialysis does not affect the pharmacokinetics of nifedipine
H Martre, R Sari, A M Taburet, C Jacobs, E Singlas, H Martre, R Sari, A M Taburet, C Jacobs, E Singlas
Abstract
To establish dosage recommendations in patients with end-stage renal disease undergoing chronic haemodialysis, nifedipine kinetics were studied between and during haemodialysis sessions. In eight patients, during the interdialytic period, peak plasma concentrations of nifedipine (29-332 ng/ml) were reached 0.5-1.0 h after administration of a single 10 mg oral dose. Elimination half-life and oral plasma clearance were respectively 2.6 +/- 0.5 h and 1 176 +/- 412 ml/min. Nifedipine plasma protein binding was decreased in uraemic patients (88.8 +/- 0.3% vs 94.4 +/- 0.1%) but not affected by haemodialysis. Removal by haemodialysis was low: the dialyser extraction ratio and the dialysis clearance were respectively 2.3 +/- 0.8% and 2.8 +/- 0.9 ml/min.
References
- Br Med J. 1971 Oct 16;4(5780):151-2
- Acta Pharmacol Toxicol (Copenh). 1974 Apr;34(4):284-94
- Arzneimittelforschung. 1974 Apr;24(4):455-66
- Biochem Pharmacol. 1976 May 15;25(10):1205-13
- Clin Pharmacokinet. 1976;1(2):121-5
- Clin Pharmacol Ther. 1977 Aug;22(2):147-53
- J Chromatogr. 1979 Jan 1;162(1):81-7
- Br J Clin Pharmacol. 1980 Nov;10(5):433-8
- J Clin Pharmacol. 1983 Apr;23(4):161-70
- Clin Pharmacol Ther. 1984 Jun;35(6):742-9
- Br J Clin Pharmacol. 1984 Dec;18(6):951-4
Source: PubMed